Delaware | 33-0903395 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
Timothy W. Trost Senior Vice President, Chief Financial Officer and Corporate Secretary Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham, NC 27713 (919) 806-1074 | Jason L. Kent, Esq. Nathan J. Nouskajian, Esq. Cooley LLP 4401 Eastgate Mall San Diego, CA 92121 (858) 550-6000 |
Large accelerated filer £ | Accelerated filer R | Non-accelerated filer £ | Smaller reporting company £ |
(Do not check if a smaller reporting company) |
Title of Securities to be Registered | Amount to be Registered 1 | Proposed Maximum Offering Price per Share (2) | Proposed Maximum Aggregate Offering Price (2) | Amount of Registration Fee |
2013 Equity Incentive Plan Common Stock, $0.001 par value per share | 1,641,271 shares (3) | $39.93 | $65,535,951.03 | $7,615.28 |
2013 Employee Stock Purchase Plan Common Stock, $0.001 par value per share | 410,317 shares (4) | 39.93 | $16,383,957.81 | $1,903.82 |
Total | 2,051,588 shares | N/A | $81,919,908.84 | $9,519.10 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Registrant’s common stock (the “Common Stock”) that become issuable under the plans by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
(2) | This estimate is made pursuant to Rule 457(c) and Rule 457(h)(1) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Common Stock on March 3, 2015, as reported on the Nasdaq Global Market. |
(4) | Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Registrant’s 2013 Employee Stock Purchase Plan (the “ESPP”) on January 1, 2015 pursuant to an “evergreen” provision contained in the ESPP. Pursuant to such provision, on January 1st of each year commencing in 2014 and ending on (and including) January 1, 2023, the number of shares authorized for issuance under the ESPP is automatically increased by a number equal to the least of: (a) 1% of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year; (b) 422,535 shares; or (c) a number determined by the Board that is less than (a) and (b). |
Item 8. | Exhibits. |
Exhibits: | |
4.1 | Amended and Restated Certificate of Incorporation of the Registrant. (1) |
4.2 | Amended and Restated Bylaws of the Registrant. (1) |
4.3 | Form of Common Stock Certificate of the Registrant. (2) |
5.1 | Opinion of Cooley LLP. |
23.1 | Consent of Ernst & Young LLP, an Independent Registered Public Accounting Firm. |
23.2 | Consent of Cooley LLP. Reference is made to Exhibit 5.1. |
24.1 | Power of Attorney. Reference is made to the signature page hereto. |
99.1 | Chimerix, Inc. 2013 Equity Incentive Plan. (3) |
99.2 | Form of Stock Option Agreement, Notice of Exercise and Form of Stock Option Grant Notice under Chimerix, Inc. 2013 Equity Incentive Plan. (2) |
99.3 | Chimerix, Inc. 2013 Employee Stock Purchase Plan. (2) |
(1) | Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on April 16, 2013. |
(2) | Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (No. 333-187145), filed on March 8, 2013, as amended. |
(3) | Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on June 23, 2014. |
CHIMERIX, INC. | |||||
By: | /s/ M. Michelle Berrey | ||||
M. Michelle Berrey, M.D., MPH | |||||
President & Chief Executive Officer |
Signature | Title | Date | ||
/s/ M. Michelle Berrey | President, Chief Executive Officer and Director | March 6, 2015 | ||
M. Michelle Berrey, MD, MPH | (Principal Executive Officer) | |||
/s/ Timothy W. Trost | Senior Vice President, Chief Financial Officer | March 6, 2015 | ||
Timothy W. Trost | and Corporate Secretary (Principal Financial and | |||
Accounting Officer) | ||||
/s/ Ernest Mario | ||||
Ernest Mario, PhD | Chairman of the Board of Directors | March 6, 2015 | ||
/s/ James M. Daly | ||||
James M. Daly | Director | March 6, 2015 | ||
/s/ Martha J. Demski | ||||
Martha J. Demski | Director | March 6, 2015 | ||
/s/ Catherine L. Gilliss | ||||
Catherine L. Gilliss, PhD, RN, FAAN | Director | March 6, 2015 | ||
/s/ John M. Leonard | ||||
John M. Leonard, MD | Director | March 6, 2015 | ||
/s/ C. Patrick Machado | ||||
C. Patrick Machado | Director | March 6, 2015 | ||
/s/ James Niedel | ||||
James Niedel, MD, PhD | Director | March 6, 2015 | ||
/s/ Ronald C. Renaud. Jr | ||||
Ronald C. Renaud, Jr | Director | March 6, 2015 | ||
/s/ Lisa Ricciardi | ||||
Lisa Ricciardi | Director | March 6, 2015 | ||
/s/ Timothy J. Wollaeger | ||||
Timothy J. Wollaeger | Director | March 6, 2015 |
Exhibits: | |
4.1 | Amended and Restated Certificate of Incorporation of the Registrant. (1) |
4.2 | Amended and Restated Bylaws of the Registrant. (1) |
4.3 | Form of Common Stock Certificate of the Registrant. (2) |
5.1 | Opinion of Cooley LLP. |
23.1 | Consent of Ernst & Young LLP, an Independent Registered Public Accounting Firm. |
23.2 | Consent of Cooley LLP. Reference is made to Exhibit 5.1. |
24.1 | Power of Attorney. Reference is made to the signature page hereto. |
99.1 | Chimerix, Inc. 2013 Equity Incentive Plan. (3) |
99.2 | Form of Stock Option Agreement, Notice of Exercise and Form of Stock Option Grant Notice under Chimerix, Inc. 2013 Equity Incentive Plan. (2) |
99.3 | Chimerix, Inc. 2013 Employee Stock Purchase Plan. (2) |
(1) | Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on April 16, 2013. |
(2) | Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (No. 333-187145), filed on March 8, 2013, as amended. |
(3) | Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on June 23, 2014. |